Cromatina/Epigenética
Os inibidores de cromatina/epigenética são compostos que modulam a estrutura e função da cromatina ou interferem em modificações epigenéticas, como a metilação do DNA e a modificação de histonas. Esses inibidores são ferramentas essenciais para estudar a regulação da expressão gênica e o papel da epigenética em doenças como o câncer, distúrbios neurológicos e anomalias do desenvolvimento. Ao direcionar os processos epigenéticos, esses inibidores podem alterar os padrões de expressão gênica e oferecer novas vias terapêuticas. Na CymitQuimica, oferecemos uma ampla seleção de inibidores de cromatina/epigenética de alta qualidade para apoiar sua pesquisa em biologia molecular, genética e epigenética.
Subcategorias de "Cromatina/Epigenética"
Foram encontrados 2235 produtos de "Cromatina/Epigenética"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Dimethyl-bisphenol A
CAS:<p>DMBPA inhibits HIF-1α, promotes its degradation by detaching Hsp90, and reduces Vegfa mRNA expression.</p>Fórmula:C17H20O2Cor e Forma:SolidPeso molecular:256.34TyK2-IN-2
CAS:<p>TyK2-IN-2 is a selective inhibitor of TYK2 (IC50s: 7 nM, 0.1 μM, and 0.05 μM for TYK2 JH2, IL-23, and IFNα).</p>Fórmula:C16H18N6OPureza:98%Cor e Forma:SolidPeso molecular:310.35SRI-42127
CAS:<p>SRI-42127 is a novel small molecule inhibitor of the RNA regulatory factor HuR that inhibits tumor growth and reduces neuropathic pain following nerve injury.</p>Fórmula:C19H20N6OPureza:99.66%Cor e Forma:SolidPeso molecular:348.4SIRT5 inhibitor 6
CAS:<p>SIRT5 inhibitor 6 is Sirtuin 5 inhibitor for sepsis-associated acute kidney injury (AKI) modulates protein succinylation and pro-inflammatory cytokine release.</p>Fórmula:C21H28N6O4SPureza:99.84%Cor e Forma:SolidPeso molecular:460.55CTX-0124143
CAS:<p>CTX-0124143 is a histone acetyltransferase inhibitor with an IC50 value of 1.0 μM for KAT6A.CTX-0124143 can be used to study cellular senescence.</p>Fórmula:C17H13FN2O3SPureza:99.16%Cor e Forma:SolidPeso molecular:344.36NSD3-IN-2
CAS:<p>NSD3-IN-2: Potent NSD3 inhibitor, IC50 17.97μM, halts NSCLC growth (H460, H1299, H1650) with anticancer effects.</p>Fórmula:C17H15N5OSCor e Forma:SolidPeso molecular:337.4NSD3-IN-3
CAS:<p>"NSD3-IN-3, a potent anticancer agent, inhibits NSD3 (IC50: 1.86 μM) and hampers H460 lung cancer cell growth."</p>Fórmula:C15H17N5O2SCor e Forma:SolidPeso molecular:331.39PRMT5-IN-C17
CAS:<p>PRMT5-IN-C17 is a novel potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor.</p>Fórmula:C18H17N3O4SCor e Forma:SolidPeso molecular:371.415WKS
CAS:<p>5WKS, or ZINC97756584, is a G9a inhibitor targeting H3K9me2 for gene silencing research in autoimmune diseases and tumors.</p>Fórmula:C24H36ClN5O2Pureza:98%Cor e Forma:SolidPeso molecular:462.03NC-III-49-1
CAS:<p>NC-III-49-1: potent BET inhibitor, binds BRD4/BRDT, inhibits cell growth, reduces c-Myc expression.</p>Fórmula:C44H50N4O11S2Cor e Forma:SoildPeso molecular:875.02CL67
CAS:<p>CL67 is a hypoxia-inducible factor pathway inhibitor. It acts by binding to a G-quadruplex higher-order structure in the HIF promoter sequence in vitro.</p>Fórmula:C38H42N10O2Cor e Forma:SolidPeso molecular:670.81HDAC-IN-44
CAS:<p>HDAC-IN-44 is an HDAC inhibitor (IC50: 61.2 nM) with strong anti-cancer effects.</p>Fórmula:C26H27BrN4O4Cor e Forma:SolidPeso molecular:539.42PDAT
CAS:<p>PDAT is a noncompetitive Indolethylamine N-methyltransferase inhibitor.</p>Fórmula:C15H23N3Pureza:98%Cor e Forma:SolidPeso molecular:245.36TM6008
CAS:<p>TM6008 is an inhibitor of prolyl hydroxylase that protects against cell death after hypoxia.</p>Fórmula:C21H17N5O3Pureza:98%Cor e Forma:SolidPeso molecular:387.39BET bromodomain inhibitor 2
CAS:<p>BET bromodomain inhibitor 2 is a potent inhibitor of the BET-type bromodomain (IC50: 14.1 μM).</p>Fórmula:C23H30N2O5SCor e Forma:SolidPeso molecular:446.56SKF 91488 dihydrochloride
CAS:<p>histamine N-methyltransferase inhibitor</p>Fórmula:C7H19Cl2N3SPureza:98%Cor e Forma:SolidPeso molecular:248.22GDC-4379
CAS:<p>GDC-4379 is a JAK1 inhibitor that can be used to study asthma.</p>Fórmula:C21H18ClF2N7O3Cor e Forma:SolidPeso molecular:489.86Y08175
CAS:<p>Y08175, a CBP Bromodomain inhibitor, IC50: 37 nM (AlphaScreen), 178.15 nM (HTRF). Useful in prostate cancer research.</p>Fórmula:C23H19FN4O5Cor e Forma:SolidPeso molecular:450.42RSC-133
CAS:<p>promotes the reprogramming of human somatic cells to pluripotent stem cells</p>Fórmula:C18H15N3O2Pureza:98%Cor e Forma:SolidPeso molecular:305.33HDAC6-IN-10
CAS:<p>HDAC6-IN-10 is a potent HDAC6 inhibitor with 0.73 nM IC50, highly selective, and hinders multiple myeloma cell growth.</p>Fórmula:C21H20N4O4Cor e Forma:SolidPeso molecular:392.41MAT2A inhibitor 3
CAS:<p>MAT2A inhibitor 3 can be used in the cancer research.</p>Fórmula:C16H14ClN3OCor e Forma:SolidPeso molecular:299.75MAT2A-IN-5
CAS:<p>MAT2A-IN-5 inhibits MAT2A in tumors, curbing growth in gastric, colon, liver, and pancreatic cancers.</p>Fórmula:C17H12ClF3N2OCor e Forma:SolidPeso molecular:352.74SIRT6-IN-1
CAS:<p>SIRT6-IN-1, a novel SIRT6 inhibitor, reduces glycemia and improves oral glucose tolerance in unfed wild-type mice.</p>Fórmula:C19H14N4O5SCor e Forma:SolidPeso molecular:410.4JAK3i
CAS:<p>JAK3i selectively inhibits JAK3 kinase, targeting the second, vital wave of STAT5 phosphorylation for T cell growth.</p>Fórmula:C18H15FN4O3Pureza:98.61% - 99.81%Cor e Forma:SolidPeso molecular:354.34ABT-472
CAS:<p>ABT-472 is a novel PARP inhibitor</p>Fórmula:C20H28N4O5Cor e Forma:SolidPeso molecular:404.46INCB054329 Racemate
CAS:<p>INCB054329 Racemate is an inhibitor of BET protein.</p>Fórmula:C19H16N4O3Pureza:98%Cor e Forma:SolidPeso molecular:348.36EML741
CAS:<p>EML741 also inhibits DNMT1 (IC50, 3.1 μM), with no effect on DNMT3a or DNMT3b.</p>Fórmula:C31H49N5O2Pureza:98%Cor e Forma:SolidPeso molecular:523.75IHCH-3064
CAS:<p>IHCH-3064: dual-action cancer immunotherapy, A2AR affinity (Ki 2.2 nM), selective HDAC1 inhibitor (IC50 80.2 nM).</p>Fórmula:C25H21N9O2Cor e Forma:SolidPeso molecular:479.49HDAC6-IN-6
CAS:<p>HDAC6-IN-6: Potent HDAC6 blocker, BBB-permeable, IC50: 0.025μM; inhibits AChE, Aβ 1-42 aggregation; promotes neurite growth, low neurotoxicity.</p>Fórmula:C20H15N3O2Cor e Forma:SolidPeso molecular:329.35A2AAR/HDAC-IN-2
CAS:<p>A2AAR/HDAC-IN-2: potent dual A2AAR/HDAC inhib., Ki 10.3 nM, IC50 18.5 nM, anti-tumor potential.</p>Fórmula:C23H26N6O4Cor e Forma:SolidPeso molecular:450.49NSC 698600
CAS:<p>NSC 698600 is a potent inhibitor of PCAF(p300/CBP-associated factor) with IC 50 of 6.51 μM that shows good inhibition activity of cancer cell proliferation [1].</p>Fórmula:C14H12N2O2SCor e Forma:SolidPeso molecular:272.32SPC-180002
CAS:<p>SPC-180002, a dual SIRT1/3 inhibitor, exhibits IC50 values of 1.13 and 5.41 μM for SIRT1 and SIRT3, respectively.</p>Fórmula:C18H23NO4Pureza:98%Cor e Forma:SolidPeso molecular:317.38JAK-IN-18
CAS:<p>"JAK-IN-18: potent JAK inhibitor for eye, skin, respiratory disease research (WO2018204238A1, comp 1)."</p>Fórmula:C27H28F2N6O3Cor e Forma:SolidPeso molecular:522.55Setin-1
CAS:<p>Setin-1 is the most potent Set7 inhibitor that acts by inhibiting the KMTase G9a.</p>Fórmula:C29H21F3N2O2Pureza:98%Cor e Forma:SolidPeso molecular:486.48GSK 525768A
CAS:<p>GSK 525768A, the inactive enantiomer of GSK525762A, exhibits no activity towards BET.</p>Fórmula:C22H22ClN5O2Cor e Forma:SolidPeso molecular:423.9OXFBD03
CAS:<p>OXFBD03 is the bromodomain and extra terminal domain bromodomain family member BRD4(1) inhibitor.</p>Fórmula:C20H19NO4Pureza:98%Cor e Forma:SolidPeso molecular:337.37LY 170198
CAS:<p>LY 170198 is a protein kinase C inhibitor.</p>Fórmula:C22H25N5O5Pureza:98%Cor e Forma:SolidPeso molecular:439.46HPCG
CAS:<p>HPCG is an inhibitor of HIF-1α prolyl hydroxylase.</p>Fórmula:C8H8N2O4Cor e Forma:SolidPeso molecular:196.16DHPCC-9
CAS:<p>DHPCC-9 is an inhibitor of Pim kinase.</p>Fórmula:C15H10N2OCor e Forma:SolidPeso molecular:234.25DC_501
CAS:<p>DC_501 is a selective non-nucleoside DNA methyltransferase 1 inhibitor.</p>Fórmula:C25H23Cl2N3OPureza:98%Cor e Forma:SolidPeso molecular:452.38Sirtuin modulator 4
CAS:<p>Sirtuin modulator 4 inhibits SIRT1 (EC50: 51-100 μM), may extend cell life and prevent diseases like diabetes and cancer.</p>Fórmula:C18H10N2O2SCor e Forma:SolidPeso molecular:318.35DCE_254
CAS:<p>DCE_254 is a novel EZH2 inhibitor, it also displays significant anti-proliferation activity against lymphoma cell lines.</p>Fórmula:C21H17N9OSPureza:98%Cor e Forma:SolidPeso molecular:443.48Langkamide
CAS:<p>Langkamide is a HIF-2 inhibitor with EC₅₀ values of 14.0 uM.</p>Fórmula:C16H17NO5Pureza:98%Cor e Forma:SolidPeso molecular:303.31I-BET151 dihydrochloride
CAS:<p>I-BET 151 dihydrochloride is a BET bromodomain inhibitor that prevents BET from recruiting to chromatin.</p>Fórmula:C23H23Cl2N5O3Pureza:98%Cor e Forma:SolidPeso molecular:488.37Vibsanin A
CAS:<p>Vibsanin A, an activator of protein kinase C (PKC) and an inhibitor of HSP90, demonstrates anti-proliferative effects on human cancer cell lines.</p>Fórmula:C25H38O4Cor e Forma:SolidPeso molecular:402.57BF1
CAS:<p>BF1 is an inhibitor of HAT (histone acetyltransferase) active both in vitro and in vivo.</p>Fórmula:C12H12ClN3SCor e Forma:SolidPeso molecular:265.76Farnesylthiotriazole
CAS:<p>Farnesylthiotriazole is a persistent PKC activator agent.</p>Fórmula:C17H27N3SPureza:98%Cor e Forma:SolidPeso molecular:305.48Tenovin-D3
CAS:<p>Tenovin-D3 is a sirtuin SirT2 inhibitor. It acts by increasing p21 (CDKN1A) expression in a p53-independent manner.</p>Fórmula:C22H27Cl3N4O3SPureza:98%Cor e Forma:SolidPeso molecular:533.9ML399
CAS:<p>ML399 inhibits menin-MLL interaction, targeting MLL leukemia cells with selective, potent action.</p>Fórmula:C27H28FN3O2Pureza:98%Cor e Forma:SolidPeso molecular:445.53iBRD4-BD1
CAS:<p>iBRD4-BD1 inhibits BRD4 bromodomain selectively with 12 nM IC50, useful in inflammation and cancer research.</p>Fórmula:C29H30F3N5OCor e Forma:SolidPeso molecular:521.58HIF-IN-33
CAS:<p>HIF-IN-33 is an inhibitor of HIF pathway.</p>Fórmula:C21H17F3N4O2Pureza:98%Cor e Forma:SolidPeso molecular:414.38CPI-905
CAS:<p>CPI-905 is a potent and selective EZH2 inhibitor with IC50 value of 39.5 nM.</p>Fórmula:C18H20N2O5Cor e Forma:SolidPeso molecular:344.36BET-BAY 002
CAS:<p>BET-BAY 002 is an effective BET bromodomain inhibitor demonstrating efficacy in vivo and in vitro against multiple myeloma and leukaemia models.</p>Fórmula:C22H18ClN5OCor e Forma:SolidPeso molecular:403.86Fagaronine chloride
CAS:<p>Fagaronine chloride is a potent inhibitor of Topoisomerases I.</p>Fórmula:C21H20ClNO4Cor e Forma:SolidPeso molecular:385.84HDAC6-IN-5
CAS:<p>HDAC6-IN-5 (11b), potent HDAC6 blocker, crosses BBB, IC50: 0.025μM, hinders Aβ1-42/AChE aggregation, boosts neurites, low toxicity.</p>Fórmula:C20H14BrN3O2Cor e Forma:SolidPeso molecular:408.25Lobelane Hydrochloride
CAS:<p>Lobelane Hydrochloride is a vesicular monoamine transporter-2 (VMAT2) inhibitor.</p>Fórmula:C22H30ClNCor e Forma:SolidPeso molecular:343.93TP-238
CAS:<p>"TP-238: Potent CECR2/BPTF dual probe; IC50: 30 nM/350 nM. Inhibits BRD9 (pIC50: 5.9); minimal activity on 338 other kinases."</p>Fórmula:C22H30N6O3SCor e Forma:SolidPeso molecular:458.58CTPB
CAS:<p>CTPB is a potent p300 histone acetyltransferase (HAT) activator that can be used in the preparation of hair growth promoters and/or hair loss treatments.</p>Fórmula:C31H43ClF3NO2Pureza:99.77%Cor e Forma:SolidPeso molecular:554.13SirReal-1
CAS:<p>SirReal-1 is an effective and selective inhibitor of Sirt2.</p>Fórmula:C18H18N4OS2Pureza:98%Cor e Forma:SolidPeso molecular:370.49Prospasmine
CAS:<p>Prospasmine is an anticholinergic.</p>Fórmula:C17H28ClNO2Pureza:98%Cor e Forma:SolidPeso molecular:313.87JAK3-IN-12
CAS:<p>JAK3-IN-12 (compound 15k) is a potent inhibitor of JAK3 (IC50: 9.5 nM) and can be used in the study of rheumatoid arthritis.</p>Fórmula:C19H19N5O4SCor e Forma:SolidPeso molecular:413.45Hns 32
CAS:<p>Hns 32 possesses antiarrhythmic properties in dog and guinea pig hearts. It also has vasodilator action.</p>Fórmula:C24H29N3Pureza:98%Cor e Forma:SolidPeso molecular:359.51p32 Inhibitor M36
CAS:<p>p32 inhibitor M36 is an inhibitor of p32 mitochondrial protein. It binds directly to p32 and inhibits the p32 association with LyP-1.</p>Fórmula:C23H28N8O2Pureza:98%Cor e Forma:SolidPeso molecular:448.52AMPK activator 1
CAS:<p>AMPK activator 1 is an AMPK activator(compound No.1-75, EC50: <0.1μM).</p>Fórmula:C32H33F3N4O3Pureza:98%Cor e Forma:SolidPeso molecular:578.62ST7710AA1
CAS:<p>ST7710AA1 inhibits PARP-1, effectively targets in vitro, and overcomes Pgp-associated multidrug resistance.</p>Fórmula:C20H22N4OCor e Forma:SolidPeso molecular:334.41NCGC00247743
CAS:<p>NCGC00247743 is an inhibitor of histone lysine demethylase KDM4.</p>Fórmula:C24H29N3O2Pureza:98%Cor e Forma:SolidPeso molecular:391.51MI-3
CAS:<p>MI-3 (Menin-MLL Inhibitor) (Menin-MLL Inhibitor) is an effective inhibitor of Menin-MLL interaction (IC50: 648 nM).</p>Fórmula:C18H25N5S2Pureza:98.66% - 99.61%Cor e Forma:SolidPeso molecular:375.55GPI-15427
CAS:<p>GPI-15427: a potent PARP-1 inhibitor, crosses the blood-brain barrier, boosts TMZ's effects on CNS tumors, and sensitizes cancer to radiotherapy.</p>Fórmula:C20H20N4O2Cor e Forma:SolidPeso molecular:348.4Binucleine 2
CAS:<p>Binucleine 2: Drosophila Aurora B kinase inhibitor (Ki=0.36μM), dose-dependent, minimal effect on human/X. laevis kinases, disrupts mitosis in fly cells.</p>Fórmula:C13H11ClFN5Cor e Forma:SolidPeso molecular:291.71GSK926
CAS:<p>GSK926 is a selective, SAM-competitive, and cell-active EZH2 inhibitor.</p>Fórmula:C29H35N7O2Cor e Forma:SolidPeso molecular:513.63CREBBP-IN-9
CAS:<p>CREBBP-IN-9, a CREBBP inhibitor, acts on the bromodomain of the protein.</p>Fórmula:C16H15N5O2SPureza:98%Cor e Forma:SolidPeso molecular:341.39CPI-1612
CAS:<p>CPI-1612: Oral EP300/CBP HAT inhibitor, IC50 8.1 nM, has anticancer properties.</p>Fórmula:C27H26N6OCor e Forma:SolidPeso molecular:450.53HDAC-IN-28
CAS:<p>HDAC-IN-28 is a novel inhibitor of HDAC that significantly inhibits tumour growth and metastasis.</p>Fórmula:C23H26N4O4SCor e Forma:SolidPeso molecular:454.54SDR-04
CAS:<p>SDR-04 inhibits BRD4-BD1 with high affinity, suppressing MV4;11 cancer cell growth as a BET inhibitor.</p>Fórmula:C19H16N4O2Cor e Forma:SolidPeso molecular:332.36H8-A5
CAS:<p>H8-A5, a HDAC8 inhibitor, shows antiproliferation activity in MDA-MB-231 cancer cells.</p>Fórmula:C14H9F3N2O2SPureza:98%Cor e Forma:SolidPeso molecular:326.29ZLD2218
CAS:<p>ZLD2218, a potent inhibitor of BRD4 with an IC50 value of 107 nM, has been demonstrated to mitigate kidney injury and fibrosis through extensive studies.</p>Fórmula:C22H18N4OCor e Forma:SolidPeso molecular:354.4TK4g
CAS:<p>TK4g, a potent JAK inhibitor, has IC50s of 12.61 nM (JAK2) & 15.80 nM (JAK3); promising for lymphoid diseases & leukemia research.</p>Fórmula:C19H19N3O4SCor e Forma:SolidPeso molecular:385.44BRD4 Inhibitor-19
CAS:<p>BRD4 inhibitors -19 are BET inhibitors that act on BRD4-BD1 (IC50: 55 nM) and can be used to study multiple myeloma.</p>Fórmula:C29H25N5O3Cor e Forma:SolidPeso molecular:491.54Arazine
CAS:<p>Arazine, a cell-permeable G protein modulator, is an isoprenylcysteine methyltransferase substrate.</p>Fórmula:C20H33NO3SPureza:90%Cor e Forma:SolidPeso molecular:367.55PARP1-IN-11
CAS:<p>PARP1-IN-11 is a potent PARP1 inhibitor (IC50=0.082 μM), also reducing PARP3, TNKS1, and TNKS2 activity.</p>Fórmula:C16H12N2O4Cor e Forma:SolidPeso molecular:296.28WD2000-012547
CAS:<p>WD2000-012547 is a selective inhibitor of poly(ADP-ribose)-polymerase (PARP-1) (pKi: 8.221).</p>Fórmula:C17H14N2OPureza:98%Cor e Forma:SolidPeso molecular:262.31NV03
CAS:<p>NV03 is a selective antagonist of the UHRF1-H3K9me3 interaction (Kd=2.4 μM) for cancer research. a ligand for E3 ligases in PROTAC synthesis.</p>Fórmula:C19H27N5O2SPureza:99.88%Cor e Forma:SolidPeso molecular:389.52MS453
CAS:<p>MS453 is a potent and selective SETD8 inhibitor with an IC50 value of 804 nM.</p>Fórmula:C20H27N5O3Cor e Forma:SolidPeso molecular:385.46NR-160
CAS:<p>NR-160 is a selective HDAC6 inhibitor (IC50=0.03μM), weaker on HDAC1-4,8, toxic to 7 cancer lines, boosts bortezomib and anthracycline effects.</p>Fórmula:C25H21F3N6O3Cor e Forma:SolidPeso molecular:510.47M122
CAS:<p>M122 is a selective histone deacetylase HDAC1 and HDAC2 inhibitor and potent antitumor agent.</p>Fórmula:C24H25N5OS2Cor e Forma:SolidPeso molecular:463.62UMB-32
CAS:<p>UMB-32: Potent, selective BRD4 inhibitor, Kd 550 nM, IC50 637 nM, also targets TAF1.</p>Fórmula:C21H23N5OCor e Forma:SolidPeso molecular:361.44CTK7A
CAS:<p>CTK7A is a water-soluble inhibitor of p300. CTK7A inhibits tumor growth in xenografted mice.</p>Fórmula:C28H24N2NaO6Pureza:98%Cor e Forma:SolidPeso molecular:507.498Bromodomain inhibitor-10
CAS:<p>Bromodomain inhibitor-10 (compound 128) suppresses BRD4-1/2 with Kd 15 nM/2.5 μM and curbs IL12p40 production.</p>Fórmula:C20H20N4O3Cor e Forma:SolidPeso molecular:364.4MAT2A inhibitor 1
CAS:<p>MAT2A inhibitor 1 is an inhibitor of methionine adenosyltransferase 2A (MATA2) (IC50 < l00 nM).</p>Fórmula:C31H22N6OSCor e Forma:SolidPeso molecular:526.61FNDR-20123 free base
CAS:<p>FNDR-20123 is a safe, oral first-in-class anti-malarial HDAC inhibitor with low IC50s against Plasmodium and human HDACs.</p>Fórmula:C21H23N5O2Cor e Forma:SolidPeso molecular:377.44TAK-418
CAS:<p>TAK-418 is an orally active LSD1/KDM1A inhibitor with a 2.9 nM IC50, potential for autism therapy.</p>Fórmula:C17H25ClN2O2SPureza:99.69%Cor e Forma:SolidPeso molecular:356.91SB-429201
CAS:<p>SB-429201 is an effective, selective inhibitor of HDAC1.</p>Fórmula:C28H24N2O3Pureza:98%Cor e Forma:SolidPeso molecular:436.5CAY10669
CAS:<p>CAY10669 inhibits PCAF (IC50 = 662 μM), is twice as potent as anacardic acid, and reduces H4 acetylation in HepG2 cells at 30-60 μM.</p>Fórmula:C20H22O4Cor e Forma:SolidPeso molecular:326.39JNJ-7925476 free base
CAS:<p>JNJ-7925476 is an TRI antidepressant agent.</p>Fórmula:C20H19NPureza:98%Cor e Forma:SolidPeso molecular:273.37PF-00956980
CAS:<p>PF-00956980: reversible JAK inhibitor, IC50: JAK1 (2.2μM), JAK2 (23.1μM), JAK3 (59.9μM), for lung/skin inflammation research.</p>Fórmula:C18H26N6OCor e Forma:SolidPeso molecular:342.44UNC6212 (Kme2)
<p>UNC6212 (Kme2), a dimethyllysine (Kme2)-containing ligand, has a K D for CBX5 of 5.7 μM .</p>Fórmula:C39H53N7O11Cor e Forma:SolidPeso molecular:795.88BAY-598 R-isomer
CAS:<p>BAY-598 R-isomer, a SMYD2-selective inhibitor, is the R-enantiomer of BAY589, not targeting PAR1.</p>Fórmula:C22H20Cl2F2N6O3Cor e Forma:SolidPeso molecular:525.34J1075
CAS:<p>J1075 is an histone deacetylase 8 (HDAC8) inhibitor.</p>Fórmula:C9H6ClNO2SPureza:98%Cor e Forma:SolidPeso molecular:227.67S-Aristeromycinylhomocysteine
CAS:<p>S-Aristeromycinylhomocysteine is an inhibitor of adenosylmethionine decarboxylase.</p>Fórmula:C15H22N6O4SCor e Forma:SolidPeso molecular:382.44(R)-OR-S1
CAS:<p>(R)-OR-S1 is a SAM-competitive, highly selective, orally bioavailable dual inhibitor of EZH1/2.</p>Fórmula:C26H34BrN3O4Pureza:98%Cor e Forma:SolidPeso molecular:532.47
